Swimming Through the Gut: Implications of Fluid Transport on the Microbiome

[1]  Yunwei Wang,et al.  Lubiprostone Decreases Mouse Colonic Inner Mucus Layer Thickness and Alters Intestinal Microbiota , 2013, Digestive Diseases and Sciences.

[2]  Eoin L. Brodie,et al.  Cystic fibrosis transmembrane conductance regulator knockout mice exhibit aberrant gastrointestinal microbiota , 2013, Gut microbes.

[3]  J. Harris,et al.  Activated fluid transport regulates bacterial-epithelial interactions and significantly shifts the murine colonic microbiome , 2012, Gut microbes.

[4]  E. Campbell,et al.  Antimicrobial Aspects of Inflammatory Resolution in the Mucosa: A Role for Proresolving Mediators , 2011, The Journal of Immunology.

[5]  Peter Mullany,et al.  Acquired Antibiotic Resistance Genes: An Overview , 2011, Front. Microbio..

[6]  R. Houwen,et al.  Guidelines for the diagnosis and management of distal intestinal obstruction syndrome in cystic fibrosis patients. , 2011, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[7]  B. McCormick,et al.  Salmonella Interaction with and Passage through the Intestinal Mucosa: Through the Lens of the Organism , 2011, Front. Microbio..

[8]  Nicola C. Reading,et al.  The Starting Lineup: Key Microbial Players in Intestinal Immunity and Homeostasis , 2011, Front. Microbio..

[9]  A. Margolles,et al.  Extracellular proteins secreted by probiotic bacteria as mediators of effects that promote mucosa-bacteria interactions. , 2010, Microbiology.

[10]  R. D. De Lisle,et al.  Lubiprostone ameliorates the cystic fibrosis mouse intestinal phenotype , 2010, BMC gastroenterology.

[11]  A. Ivanov,et al.  Cytoskeletal regulation of epithelial barrier function during inflammation. , 2010, The American journal of pathology.

[12]  Jerrold R. Turner,et al.  Intestinal mucosal barrier function in health and disease , 2009, Nature Reviews Immunology.

[13]  G. Glenn,et al.  Toxin-Mediated Effects on the Innate Mucosal Defenses: Implications for Enteric Vaccines , 2009, Infection and Immunity.

[14]  J. Escher,et al.  Activation of intestinal Cl- secretion by lubiprostone requires the cystic fibrosis transmembrane conductance regulator. , 2009, Gastroenterology.

[15]  G. Gamba.  Molecular physiology and pathophysiology of electroneutral cation-chloride cotransporters. , 2005, Physiological reviews.

[16]  T. Churchill,et al.  Activation of AMP-activated protein kinase reduces cAMP-mediated epithelial chloride secretion. , 2003, American journal of physiology. Gastrointestinal and liver physiology.

[17]  K. Madsen,et al.  Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice. , 1999, Gastroenterology.

[18]  R. Boucher,et al.  Introduction to section I: overview of approaches to study cystic fibrosis pathophysiology. , 2011, Methods in molecular biology.

[19]  W. D. de Vos,et al.  Interactomics in the human intestine: Lactobacilli and Bifidobacteria make a difference. , 2008, Journal of clinical gastroenterology.

[20]  S. Rowe,et al.  Cystic fibrosis. , 2005, The New England journal of medicine.

[21]  K. Barrett,et al.  Chloride secretion by the intestinal epithelium: molecular basis and regulatory aspects. , 2000, Annual review of physiology.